NorthWest Biotherapeutics Inc (NWBO)

[DocLee]

I have been supportive of management ever since I first bought into the company in 2013 and I have tacitly accepted the reasons given for Management's decision to restrict the supply of information beyond the absolute legal requirement. It is in this frame of mind that I fully expect management to be working their socks off behind the scenes to launch DCVax-L onto the medical profession and into the public gaze as soon as the MHRA gives its approval.

A vital part of that scenario is that a treatment price acceptable to NICE will have already been negotiated. I don't expect anything less than that because otherwise that will enable those disgusting specimens of humanity who infest this board (and others) to continue with their disgraceful agenda.

If it transpires that in the 26 months between November 2022 when the phase 3 trial results were first published and now management has not been seriously addressing the price of DCVax-L with NICE, my faith in them will be destroyed.

As far as I am concerned, if that transpires they will have a serious case to answer as to whether or not they are guilty of dereliction of their duty (or whatever the legalese might be).